An Online Partnering and Valuation Platform for Life Sciences Industry
+1 973-460-2680

Latest News

Even after FDA's coronavirus vaccine guidance, the emergency path remains a mystery: GlobalData esagonowsky Wed, 07/01/2020 - 11:20
Where are U.S. drugs really made? A new Senate bill aims to find out kblankenship Wed, 07/01/2020 - 10:53
Pfizer, BioNTech coronavirus vaccine candidate gins up antibodies in early trial esagonowsky Wed, 07/01/2020 - 09:54
Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies arlene.weintraub Wed, 07/01/2020 - 09:12
Former Indivior CEO pleads guilty in federal Suboxone probe a day after stepping down from post kblankenship Wed, 07/01/2020 - 09:02
Pfizer, Merck KGaA's Bavencio breaks into new bladder cancer field with latest FDA nod chelfand Wed, 07/01/2020 - 01:34
With more nays than yeas for Gilead's remdesivir pricing, are pharma's rep gains sunk? beth.bulik Tue, 06/30/2020 - 10:03
GSK's Duvroq, Akebia's Vafseo win global first nods in Japan to challenge Astellas' anemia drug aliu Tue, 06/30/2020 - 09:45
FDA will require 50% efficacy for COVID-19 vaccines. How high is that bar? esagonowsky Tue, 06/30/2020 - 09:20
Merck's Keytruda lands new colorectal cancer nod, its 2nd biomarker-based OK this month chelfand Tue, 06/30/2020 - 04:00
Novavax hires new manufacturing chief to take COVID-19, flu vaccine hopefuls across the finish line kblankenship Mon, 06/29/2020 - 23:03
Alnylam's RNAi therapy Givlaari shows lasting effect one year into treatment, new data show kblankenship Mon, 06/29/2020 - 18:15
With calls for American-made drugs on the rise, a Michigan CDMO is scaling up to meet demand kblankenship Mon, 06/29/2020 - 15:57
Intercept's NASH hopeful spurned by FDA, raising questions for other companies in the race esagonowsky Mon, 06/29/2020 - 11:29
Piramal finds long-sought investor for $490M boost to M&A war chest kblankenship Mon, 06/29/2020 - 11:03
FiercePharmaPolitics—How would a Biden White House handle drug prices? Depends on congressional races, analysts say esagonowsky Mon, 06/29/2020 - 09:44
Gilead's long-awaited remdesivir price is $3,120, in line with watchdog estimates aliu Mon, 06/29/2020 - 09:01
AstraZeneca reaches supply deal with Brazilian government to produce millions of doses of COVID-19 shot kblankenship Mon, 06/29/2020 - 08:47
WHO, global partners launch $18B COVID-19 vaccine initiative esagonowsky Fri, 06/26/2020 - 15:16
Chiasma secures FDA approval for acromegaly pill Mycapssa years after near-catastrophic rejection kblankenship Fri, 06/26/2020 - 12:49
Chasing GW's Epidiolex, Zogenix finally wins FDA nod for rare childhood epilepsy drug Fintepla aliu Fri, 06/26/2020 - 11:26
'No presents anymore': Inside Novartis' scheme to boost Lucentis sales in Greece esagonowsky Fri, 06/26/2020 - 10:31
Novartis gives up on Xiidra's EU approval, endangering payoff from $3.4B Takeda buyout aliu Fri, 06/26/2020 - 09:58
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful kblankenship Fri, 06/26/2020 - 08:07
FiercePharmaAsia—WuXi NextCODE rebrand; remdesivir generic prices; Sinopharm COVID-19 vax phase 3 aliu Fri, 06/26/2020 - 07:37
Annexon grabs $100M from a host of top VC firms for complement therapies badams Thu, 07/02/2020 - 08:00
British cell therapy biotech Rexgenero nabs life science veteran as CMO badams Thu, 07/02/2020 - 06:32
Pfizer-backed Bolt Therapeutics strikes $93.5M funding round as lead med hits the clinic badams Thu, 07/02/2020 - 05:30
5 FDA-approved antivirals could target COVID-19: study arlene.weintraub Wed, 07/01/2020 - 11:22
Amylyx Pharmaceuticals nabs $30M for ALS, Alzheimer's work badams Wed, 07/01/2020 - 09:57
Sumitomo merges U.S. biotechs to create oncology division ntaylor Wed, 07/01/2020 - 08:53
Ultrafast insulin from Stanford slashes peak time to efficacy in pig diabetes models aliu Wed, 07/01/2020 - 08:15
More than two-thirds of trials hit by COVID-19 enrollment halts, with midstage tests the worst affected badams Wed, 07/01/2020 - 08:08
Analysts hail Akero's midphase NASH data as best in class ntaylor Wed, 07/01/2020 - 08:01
2 months after launch, QurAlis nabs early ALS compounds from Eli Lilly badams Wed, 07/01/2020 - 07:31
After its $2B Gilead pact, Goldfinch Bio nabs a cool $100M series B badams Tue, 06/30/2020 - 08:46
Newly merged Mereo BioPharma looks to OncoMed for R&D hires badams Tue, 06/30/2020 - 08:10
Takeda pens $900M biobucks pact with Carmine for non-viral gene therapy work badams Tue, 06/30/2020 - 07:31
Freeline closes major $120M funding round as Novo's VC firm jumps on board badams Tue, 06/30/2020 - 05:29
Genmab, Seattle Genetics eye FDA filing for new cancer med after latest data drop ntaylor Tue, 06/30/2020 - 03:58
Heron's wings clipped again with another FDA rejection for opioid alternative badams Mon, 06/29/2020 - 09:13
After patients die, FDA clamps hold on Astellas gene therapy trial ntaylor Mon, 06/29/2020 - 07:56
After CureVac nabs government backing, BioNTech sees $250M private investment badams Mon, 06/29/2020 - 07:27
2 early-stage biotechs gun for $175M as IPO waters remain warm badams Mon, 06/29/2020 - 05:42
Using gene editing to keep cholesterol down and heart attacks at bay aalidrus Fri, 06/26/2020 - 18:13
Awaiting IPO, Poseida Therapeutics nips in a quick $110M series D badams Fri, 06/26/2020 - 08:25
EMA picks WHO's Cooke to replace Rasi as executive director ntaylor Fri, 06/26/2020 - 08:18
Natural killer biotech Artiva launches with $78M, industry veterans badams Fri, 06/26/2020 - 05:32
AbbVie's Allergan, Molecular Partners hit by FDA eye drug rejection badams Fri, 06/26/2020 - 03:45
Chutes & Ladders—Allergan ex-CEO Saunders takes board seat at BridgeBio kblankenship Thu, 06/25/2020 - 17:40

Home